Infection Control: New York State Mandatory Training

Chapter Six - Element VI


Chapter 1: Element I

Chapter 2: Element II

Chapter 3: Element III

Chapter 4: Element IV

Chapter 5: Element V

Chapter 7: Conclusion

Resources

References

Take Test

Exit to Menu





Element VI: The prevention and management of infectious or communicable disease in healthcare workers.

Because of their contact with patients or infective material from patients, many healthcare workers (e.g., physicians, nurses, emergency medical personnel, dental professionals and students, medical and nursing students, laboratory technicians, hospital volunteers, and administrative staff, etc.) and healthcare organizations utilize multiple interventions to prevent and/or manage infections in healthcare workers (CDC, 1997).

Initially, new employees are generally required to have a pre-employment physical; presumably any infection can be identified at that time and treatment initiated or management strategies employed prior to contact with patients or coworkers. Because healthcare workers are at risk for exposure to and possible transmission of vaccine-preventable diseases, maintenance of immunity is an essential part of prevention and infection control programs for healthcare workers. Optimal use of immunizing agents safeguards the health of workers and protects patients from becoming infected through exposure to infected workers (CDC, 1997).

On the basis of documented nosocomial transmission, healthcare workers are considered to be at significant risk for acquiring or transmitting (CDC, 1997):

  • Hepatitis B,
  • Influenza,
  • Measles,
  • Mumps,
  • Rubella, and
  • Varicella.

All of these diseases are vaccine-preventable (CDC, 1997).

In addition to pre-employment screening or testing for infection and illness, vaccinations for vaccine-preventable illnesses, maintenance of good health, and the utilization of engineering and work practice controls are all methods to minimize the risk of acquiring or transmitting an infectious disease.

The estimated number of occupational HBV infections among U.S. healthcare workers has decreased significantly over the last 20 years. Data from the National Notifiable Diseases Surveillance System (NNDSS) indicated a 96% decline in HBV infections among healthcare workers over a 17-year period-from nearly 11,000 cases in 1983 to fewer than 400 in 1999. This reduction is largely due to the adoption of universal precautions in the mid-1980s by healthcare facilities and the 1992 OSHA Bloodborne Pathogen Standard (29 CFR 1910.1030), which required employers to offer HBV vaccinations to exposed workers (NIOSH, 2004).

ACIP has developed the following adult immunization schedule for October 2005 - November 2006.

View the Adult Immunization Schedule.

During the time frame from 1981 through December 2002, 57 cases of documented occupational transmission of HIV to healthcare workers occurred. In that same time frame, 139 cases of occupational transmission of HIV to healthcare workers were possible (NIOSH, 2004).

Most documented cases of occupational HIV transmission occurred among nurses (24 cases or 42.1%) and laboratory workers (19 cases or 33.3%). These cases were reported to the HIV/AIDS Reporting System. Among the documented cases of HIV following occupational exposure, 84% resulted from percutaneous exposure (NIOSH, 2004).

Exposure prevention remains the primary strategy for reducing occupational bloodborne pathogen infections. Despite the various controls in place to prevent occupational transmission, sometimes healthcare workers do come into contact with infectious agents (CDC, 2001).

Healthcare facilities will have policies and procedures for the prevention of occupational exposure in place as part of their administrative controls related to infection control, however, these facilities will also have policies and procedures in place regarding reporting, evaluation, counseling, treatment and follow-up of occupational exposure (CDC, 2001).

Healthcare workers must be educated concerning the risk of and prevention for bloodborne pathogens, including the need to be vaccinated against HBV. Employers are required to establish exposure control plans that include post-exposure followup for employees and to comply with the incident reporting requirements of the 1992 OSHA Bloodborne Pathogens Standard. Access to clinicians who can provide post-exposure care should be available during all working hours, including nights and weekends. Hepatitis B immunoglobulin (HBIG), HBV vaccine and antiretroviral agents for post-exposure prophylaxis should be available in a timely manner, either by providing access onsite or by developing linkages with providers or facilities that can provide such service off-site. Those individuals who are responsible to provide post-exposure management must be knowledgeable about the evaluation and treatment protocols and the facility's plans for accessing post-exposure medications (CDC, 2001).

Healthcare workers must be informed to report occupational exposures immediately after they occur because prophylactic treatment is most effective when administered as soon after the exposure as possible (CDC, 2001).

In the event that wounds or skin sites have been in contact with blood or body fluids, the sites must immediately be washed with soap and water; mucous membranes should be flushed with water. No evidence exists that using antiseptics for wound care or expressing fluid by squeezing the wound further reduces the risk of transmission; however, the use of antiseptics is not contraindicated (CDC, 2001).

In the event of an occupational exposure, the exposure and post-exposure management should be recorded in the exposed person's medical record. A facility may have a specific form for such an exposure. Employers must follow all federal and state requirements for recording and reporting occupational injuries and exposures (CDC, 2001).

The CDC (2001) recommends that the following information be recorded in the exposed person's confidential medical record:

  • Date and time of exposure;
  • Details of the procedure being performed, including where and how the exposure occurred; if related to a sharp device, the type and brand of device, and how and when in the course of handling the device the exposure occurred;
  • Details of the exposure, including type and amount of fluid or material and the severity of the exposure (e.g., for a percutaneous exposure, depth of injury and whether fluid was injected; for a skin or mucous membrane exposure, the estimated volume of material) and the condition of the skin (e.g., chapped abraded, intact).
  • Details about the exposure source (e.g., whether the source material contained HBV, HCV or HIV; if the source is HIV-infected, the stage of disease, history of antiretroviral therapy, viral load, antiretroviral resistance information, if known).
  • Details about the exposed person (e.g., HBV vaccination and vaccine response status).
  • Details about counseling, post-exposure management and follow-up.

The specific details about post-exposure management and treatment can be found in the Updated US Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV (2001) available at
http://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf.

Continue on to Chapter 7: Conclusion